A5053919172- Autoimmune Neurological Disorders and Treatments
- Epilepsy research and treatment
- Meningioma and schwannoma management
- Bacterial Infections and Vaccines
- RNA regulation and disease
- Neurotransmitter Receptor Influence on Behavior
- Infectious Encephalopathies and Encephalitis
- Alcohol Consumption and Health Effects
- Trigeminal Neuralgia and Treatments
- Nail Diseases and Treatments
- EEG and Brain-Computer Interfaces
- Neurobiology of Language and Bilingualism
- Fungal Infections and Studies
- Neurological and metabolic disorders
- Salivary Gland Disorders and Functions
- Diet and metabolism studies
- Parvovirus B19 Infection Studies
- Herpesvirus Infections and Treatments
- Amino Acid Enzymes and Metabolism
- Renal Diseases and Glomerulopathies
- Chemical Synthesis and Analysis
- Transcranial Magnetic Stimulation Studies
- interferon and immune responses
- Viral Infections and Immunology Research
- Metalloenzymes and iron-sulfur proteins
Kitasato University Hospital
2016-2021
Azabu University
2009-2018
Ehime Prefectural Central Hospital
2017
Shizuoka City Shimizu Hospital
2017
Nippon Medical School
2017
Fukushima Medical University Hospital
2017
keiyu Hospital
2017
Kitasato University
2008-2010
To report the distinctive clinical features of cryptogenic new-onset refractory status epilepticus (C-NORSE) and C-NORSE score based on initial assessments.A retrospective study was conducted for 136 patients with clinically suspected autoimmune encephalitis who underwent testing autoantibodies to neuronal surface antigens between January 1, 2007, August 31, 2016. Eleven were identified. Their compared those 32 anti-NMDA receptor (NMDARE).The outcome 11 (median age, 27 years; 7 [64%] women)...
To determine whether a clinically based score predicts cryptogenic new-onset refractory status epilepticus (C-NORSE) at the early stage of (SE) with prominent motor symptoms (SE-M) unclear etiology.The (range 0-6) included 6 clinical features: highly refractoriness to antiseizure drugs, previously healthy individual, presence prodromal fever, absence psychobehavioral or memory alterations, dyskinesias, and symmetric brain MRI abnormalities (the first 2 mandatory). We retrospectively assessed...
Abstract Objectives Status epilepticus (SE) can be associated with neuronal surface antibodies (NS‐Abs) but NS‐Ab detection rate remains unknown in patients SE of unclear etiology at symptom presentation suspected having an autoimmune (SE autoimmune). We aimed to determine the and clinical features that predict presence NS‐Abs autoimmune. Methods retrospectively reviewed information 137 who underwent testing for between January 2007 September 2020. were examined both serum cerebrospinal...
The N-methyl-D-aspartate receptor subunit 2B (GluN2B) is involved in regulation of anxiety and depression nervous activity the brain. Single nucleotide polymorphisms GluN2B gene (GRIN2B) are associated with human mental function behaviour. We investigated whether four GRIN2B (rs7301328, rs1806201, rs1805247, rs1805502) affect characterisation personality traits.In 248 young people, were analysed, traits assessed using Neuroticism Extraversion Openness-Five Factor Inventory (NEO-FFI)...
Key Clinical Message Normal‐appearing evoked potentials during the acute stage of disease despite persistent coma may predict subsequent functional recovery brain in a pediatric case necrotizing encephalopathy, indicating that potential studies are useful for predicting outcome brain.
To validate a clinically-based score that predicts cryptogenic new-onset refractory status epilepticus (C-NORSE) at early stage of (SE).
To determine the frequency of antibodies to neuronal surface antigens (NSA-abs) in patients with possible autoimmune encephalitis (AE) or new-onset refractory status epilepticus (NORSE).